QTRX
vs
S&P 500

Over the past 12 months, QTRX has underperformed S&P 500, delivering a return of -74% compared to the S&P 500's 12% growth.
Stocks Performance
QTRX vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
Performance Gap
QTRX vs S&P 500
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
Performance By Year
QTRX vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
Competitors Performance
Quanterix Corp vs Peers
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
UK |
E
|
Eight Capital Partners PLC
F:ECS
|
|
CA |
![]() |
Australian Goldfields Ltd
OTC:GRXXF
|
|
US |
G
|
GE Vernova LLC
NYSE:GEV
|
|
IN |
S
|
SAB Industries Ltd
BSE:539112
|
|
US |
C
|
China Industrial Group Inc
OTC:CIND
|
|
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
|
US |
![]() |
Schlumberger NV
NYSE:SLB
|
|
US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
|
US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
|
ID |
![]() |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
Quanterix Corp
Glance View
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 460 full-time employees. The company went IPO on 2017-12-07. The firm is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to reliably detect protein biomarkers at extremely low concentrations in blood, serum and other fluids. Its products include HD-X Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, and 2470 Arrayer. The company also supplies NF-Light antibodies and ELISA kits, which offer solutions for the detection of neurofilament light (Nf-L) for the development of therapeutics and diagnostics for neurodegenerative conditions. Its portfolio of available kits spans multiple therapeutic areas, including cardiology, infectious disease, inflammation, neurology, and oncology. The company provides services through its Simoa Accelerator Laboratory.
